Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Oral glucose tolerance testing"'
Autor:
Vanessa Guerreiro, Isabel Maia, João Sérgio Neves, Daniela Salazar, Maria João Ferreira, Fernando Mendonça, Maria Manuel Silva, Marta Borges-Canha, Sara Viana, Cláudia Costa, Jorge Pedro, Ana Varela, Eva Lau, Paula Freitas, Davide Carvalho, AMTCO Group
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 14, Iss 1, Pp 1-7 (2022)
Abstract Background One hour plasma glucose concentration (1hPG) during an oral glucose tolerance test (OGTT) may be an alternative to 2-h plasma glucose concentration (2hPG) in the identification of individuals at increased risk of hyperglycaemia, a
Externí odkaz:
https://doaj.org/article/cca21cd3ec3445fd8be637b25039bd45
Autor:
Hacer Eroglu İÇLİ, Tevfik Berk BİLDACI
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 65, Iss 6, Pp 747-751 (2021)
ABSTRACT Objective: Oral glucose tolerance testing (OGTT) is the current recommended approach for the diagnosis of gestational diabetes mellitus (GDM). Visfatin is a type of novel adipokine of interest that mostly participates in glucose metabolism a
Externí odkaz:
https://doaj.org/article/b94c3d158e4d45cab932ce85906f5776
Autor:
Christine L. Chan, Andrea Granados, Amir Moheet, Sachinkumar Singh, Timothy Vigers, Ana Maria Arbeláez, Yaling Yi, Shanming Hu, Andrew W. Norris, Katie Larson Ode
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 30, Iss , Pp 100311- (2022)
Background: Diabetes is prevalent among people with CF (PwCF) and associated with worse clinical outcomes. CFTR modulators are highly effective in improving the disease course of CF. However, the effects of elexacaftor/tezacaftor/ivacaftor (ETI) on g
Externí odkaz:
https://doaj.org/article/316d9cb57ebf475b8bd56a5deb9465d7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 26, Iss , Pp 100275- (2021)
Oral glucose tolerance testing (OGTT) is the primary method to screen for and diagnose cystic fibrosis-related diabetes (CFRD). Diagnostic thresholds as currently defined are based on microvascular complications seen in type 2 diabetes. Abnormal gluc
Externí odkaz:
https://doaj.org/article/e1b14997e1744662a0f86b93285e9ee4
Publikováno v:
BMC Pregnancy and Childbirth, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background The oral glucose-tolerance test (OGTT) is currently the standard method for diagnosis of gestational diabetes (GDM). We conducted a post hoc analysis using the Australian Hyperglycemia and Adverse Pregnancy Outcome (HAPO) data to
Externí odkaz:
https://doaj.org/article/86401967299b4039ab761157aa96987e
Autor:
Belén Pérez-Pevida, Jorge M. Núñez-Córdoba, Sonia Romero, Alexander Dimitri Miras, Patricia Ibañez, Neus Vila, María Ángeles Margall, Camilo Silva, Javier Salvador, Gema Frühbeck, Javier Escalada
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-11 (2019)
Abstract Background and aims Obesity is associated with impaired glucose tolerance which is a risk factor for cardiovascular risk. However, the oral glucose tolerance test (OGTT) is not usually performed in patients with normal fasting glycaemia, thu
Externí odkaz:
https://doaj.org/article/a2baf092de5d4b579d6eb5ccb70b949f
Autor:
Chhavi Chadha, Anastassios G. Pittas, Christine W. Lary, William C. Knowler, Ranee Chatterjee, Lawrence S. Phillips, Vanita R. Aroda, Michael R. Lewis, Richard Pratley, Myrlene A. Staten, Jason Nelson, Neda Rasouli, Irwin Brodsky
Publikováno v:
Metabolism Open, Vol 6, Iss , Pp 100031- (2020)
Aims: To assess whether meeting both fasting plasma glucose (FPG) and HbA1c criteria for prediabetes in people at high risk indicates with near certainty the presence of dysglycemia on repeat testing. Methods: Observational study using data from Vita
Externí odkaz:
https://doaj.org/article/0b41e4074a8a4235baf6cedc6c866c25
Autor:
Hart, Phil A, Papachristou, Georgios I, Park, Walter G, Dyer, Anne-Marie, Chinchilli, Vernon M, Afghani, Elham, Akshintala, Venkata S, Andersen, Dana K, Buxbaum, James L, Conwell, Darwin L, Dungan, Kathleen M, Easler, Jeffrey J, Fogel, Evan L, Greenbaum, Carla J, Kalyani, Rita R, Korc, Murray, Kozarek, Richard, Laughlin, Maren R, Lee, Peter J, Maranki, Jennifer L, Pandol, Stephen J, Phillips, Anna Evans, Serrano, Jose, Singh, Vikesh K, Speake, Cate, Tirkes, Temel, Toledo, Frederico GS, Trikudanathan, Guru, Vege, Santhi Swaroop, Wang, Ming, Yazici, Cemal, Zaheer, Atif, Forsmark, Christopher E, Bellin, Melena D, Yadav, Dhiraj, Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC)
Publikováno v:
Pancreas, vol 51, iss 6
Acute pancreatitis (AP) is a disease characterized by an acute inflammatory phase followed by a convalescent phase. Diabetes mellitus (DM) was historically felt to be a transient phenomenon related to acute inflammation; however, it is increasingly r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::c79543370cff622d3728423cdb602e58
https://escholarship.org/uc/item/6r6645nd
https://escholarship.org/uc/item/6r6645nd
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.